Cargando…

Tumor Molecular and Microenvironment Characteristics in EBV-Associated Malignancies as Potential Therapeutic Targets: Focus on Gastric Cancer

Although most people are infected with Epstein-Barr Virus (EBV) during their lifetime, only a minority of them develop an EBV-associated malignancy. EBV acts in both direct and indirect ways to transform infected cells into tumor cells. There are multiple ways in which the EBV, host, and tumor envir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atri-Schuller, Aviva, Abushukair, Hassan, Cavalcante, Ludimila, Hentzen, Stijn, Saeed, Azhar, Saeed, Anwaar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689242/ https://www.ncbi.nlm.nih.gov/pubmed/36421674 http://dx.doi.org/10.3390/cimb44110390

Ejemplares similares

Targeted and Immunotherapy Approaches in HER2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma: A New Era
por: Radford, Maluki, et al.
Publicado: (2023)

Insight on BRAF(V600E) mutated colorectal cancer immune microenvironment
por: Abushukair, Hassan Mohammed, et al.
Publicado: (2022)

Hepatocellular carcinoma and immunotherapy: Beyond immune checkpoint inhibitors
por: Abushukair, Hassan Mohammed, et al.
Publicado: (2022)

GSK-3β in Pancreatic Cancer: Spotlight on 9-ING-41, Its Therapeutic Potential and Immune Modulatory Properties
por: Park, Robin, et al.
Publicado: (2021)

The Crosstalk between Microbiome and Immunotherapeutics: Myth or Reality
por: Tojjari, Alireza, et al.
Publicado: (2022)

SLAM Modification as an Immune-Modulatory Therapeutic Approach in Cancer
por: Tojjari, Alireza, et al.
Publicado: (2023)

Overcoming Immune Checkpoint Therapy Resistance with SHP2 Inhibition in Cancer and Immune Cells: A Review of the Literature and Novel Combinatorial Approaches
por: Tojjari, Alireza, et al.
Publicado: (2023)

A Comprehensive Review on Cancer Vaccines and Vaccine Strategies in Hepatocellular Carcinoma
por: Tojjari, Alireza, et al.
Publicado: (2023)

Genomic and Transcriptomic Predictors of Response to Immune Checkpoint Inhibitors in Melanoma Patients: A Machine Learning Approach
por: Ahmed, Yaman B., et al.
Publicado: (2022)

EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies
por: Williams, Marshall V., et al.
Publicado: (2023)

Cancer-Associated Fibroblasts in Gastrointestinal Cancers: Unveiling Their Dynamic Roles in the Tumor Microenvironment
por: Al-Bzour, Noor N., et al.
Publicado: (2023)

Efficacy and Safety of Rechallenge with BRAF/MEK Inhibitors in Advanced Melanoma Patients: A Systematic Review and Meta-Analysis
por: Priantti, Jonathan N., et al.
Publicado: (2023)

Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival
por: Choucair, Khalil, et al.
Publicado: (2023)

Real world outcomes in patients with neuroendocrine tumor receiving peptide receptor radionucleotide therapy
por: Hentzen, Stijn, et al.
Publicado: (2023)

Unremitting chronic skin lesions: a case of delayed diagnosis of glucagonoma
por: Kawsar, Hameem I., et al.
Publicado: (2019)

The Therapeutic Potential of Targeting BARF1 in EBV-Associated Malignancies
por: Lo, Angela Kwok-Fung, et al.
Publicado: (2020)

EBV Positive Gastric Carcinomas and Their Clinicopathological Characteristics
por: Ognjenovic, Ljubomir, et al.
Publicado: (2018)

The EBV Gastric Cancer Resource (EBV-GCR): A Suite of Tools for Investigating EBV-Associated Human Gastric Carcinogenesis
por: Salnikov, Mikhail Y., et al.
Publicado: (2023)

Anti-Inflammatory and Immune Properties of Polyunsaturated Fatty Acids (PUFAs) and Their Impact on Colorectal Cancer (CRC) Prevention and Treatment
por: Tojjari, Alireza, et al.
Publicado: (2023)

Immuno-Oncotherapeutic Approaches in Advanced Hepatocellular Carcinoma
por: Park, Robin, et al.
Publicado: (2020)

The role of EBV-encoded miRNA in EBV-associated gastric cancer
por: Liu, Ting, et al.
Publicado: (2023)

Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens
por: Rozman, Marija, et al.
Publicado: (2022)

The integration of immune checkpoint inhibitors with VEGF targeted agents in advanced gastric and gastroesophageal adenocarcinoma: a review on the rationale and results of early phase trials
por: Saeed, Anwaar, et al.
Publicado: (2021)

Differences in the Tumor Microenvironment of EBV-Associated Gastric Cancers Revealed Using Single-Cell Transcriptome Analysis
por: Salnikov, Mikhail Y., et al.
Publicado: (2023)

Differences in Gastric Carcinoma Microenvironment Stratify According to EBV Infection Intensity: Implications for Possible Immune Adjuvant Therapy
por: Strong, Michael J., et al.
Publicado: (2013)

Plasma EBV DNA as a prognostic factor in EBV associated gastric cancer: a multicenter, prospective study (EBV PRESAGE study)
por: Alberti, Andrea, et al.
Publicado: (2023)

Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma
por: Choi, Su Jin, et al.
Publicado: (2019)

Pyloric stent insertion in malignant gastric outlet obstruction: moving beyond palliation
por: Saeed, Saad Muhammad, et al.
Publicado: (2021)

Composite Lymphoma with Follicular Lymphoma Transformation to Clonally Related Epstein–Barr Virus (EBV) Positive Diffuse Large B-Cell Lymphoma and EBV-PositiveClassic Hodgkin Lymphoma
por: Ryder, Christopher B., et al.
Publicado: (2023)

Vasculogenic mimicry formation in EBV-associated epithelial malignancies
por: Xiang, Tong, et al.
Publicado: (2018)

Revisiting the Tissue Microenvironment of Infectious Mononucleosis: Identification of EBV Infection in T Cells and Deep Characterization of Immune Profiles
por: Barros, Mário Henrique M., et al.
Publicado: (2019)

The interplay between Epstein-Bar virus (EBV) with the p53 and its homologs during EBV associated malignancies
por: Chatterjee, Koustav, et al.
Publicado: (2019)

Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
por: Iizasa, Hisashi, et al.
Publicado: (2012)

The Role of EBV-Induced Hypermethylation in Gastric Cancer Tumorigenesis
por: Stanland, Lyla J., et al.
Publicado: (2020)

EBV and MSI Status in Gastric Cancer: Does It Matter?
por: do Nascimento, Catarina Neto, et al.
Publicado: (2022)

Differential expression of EBV proteins LMP1 and BHFR1 in EBV-associated gastric and nasopharyngeal cancer tissues
por: WANG, AILIANG, et al.
Publicado: (2016)

Tracking EBV-encoded RNAs (EBERs) from the nucleus to the excreted exosomes of B-lymphocytes
por: Ahmed, Waqar, et al.
Publicado: (2018)

Perspectives for immunotherapy of EBV‐associated GLELC: A relatively “hot” tumor microenvironment
por: Lei, Yanna, et al.
Publicado: (2023)

GMP development and preclinical validation of CAR-T cells targeting a lytic EBV antigen for therapy of EBV-associated malignancies
por: Zhang, Xi, et al.
Publicado: (2023)

The characteristics and clinical relevance of tumor fusion burden in non-EBV (+) gastric cancer with MSS
por: Zhu, Yongjun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_j7bolsi20c646hk7gmqugfe4n3